CutisCare

CutisCare is a U.S. healthcare services company focused on outpatient wound care and hyperbaric oxygen therapy program management for hospitals, academic medical centers, health systems, and physician practices. Rather than developing therapeutics, the company provides turnkey clinical, operational, compliance, education, and business support for wound centers and hyperbaric medicine programs. Its offerings have included both hospital-based wound center management and physician office-based services, with the office-based division being renamed RegenQuest in 2025. In October 2025, RestorixHealth completed the acquisition of CutisCare’s hospital-based business to create a larger wound and hyperbaric center management platform. CutisCare is therefore healthcare-related and commercial, but it is not a biotech or drug-development company.